WHITE PAPERS
Read our white papers
WHITE PAPER
Before the First Patient: Simulating Drug Development In Silico: From Molecule to Clinic
This paper presents MOL2CLIN, an in silico workflow that simulates the full drug development process, from molecular structure to predicted clinical trial outcomes, before a single patient is enrolled. Through a four-stage workflow with human-review checkpoints, it aims to reduce attrition and enable earlier go/no-go decisions in oncology drug development.
WHITE PAPER
Advancing Women’s Health with In Silico Design and Evaluation of Clinical Studies
This paper discusses how computer simulations can improve drug development for women, especially pregnant, childbearing, and lactating women, by accounting for their unique biology and optimizing treatments.
WHITE PAPER
A New Frontier in Clinical Trials: The Promise of Synthetic Control Arms
In this white paper, we explore the concept of Synthetic Control Arms and their potential to transform the clinical trial landscape.
WHITE PAPER
In Silico Standard Testing
This white paper has the aim of shedding light on the concept of In Silico Standard Testing for medical devices and highlighting its benefits, with an emphasis on the orthopedic and cardiovascular sectors.
WHITE PAPER
Shedding light on Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm
The scope of this white paper is to clarify the different definitions of Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm in the Pharma and MedTech fields.